Embattled genetics testing giant 23andMe is thinking of selling itself as it runs out of cash. The company needs ...
At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.
Me (ME), the company that popularized consumer genetic testing, announced Tuesday that it is once again exploring “strategic ...
By the 2023 fiscal year, 23andMe had reported a net loss of $312 million and its individual share price has plummeted a ...
In a landmark decision from the FDA, genomics firm 23andMe's direct-to-consumer genetics test has been approved in 10 conditions. Originally given FDA marketing authorisation in February 2015 as a ...
23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter results that showed an 8% drop in consumer services revenue year over year ...
WELL Daryl Perez knew he had been adopted for a long time. After taking a 23andMe test, he discovered a lineage he didn't know still existed. Last February, Daryl Perez took a 23andMe test to find ...
23andMe has been exploring a possible sale of its telehealth business, Business Insider has learned. The struggling health company bought the virtual-care startup Lemonaid in 2021 for $400 million ...
Just google 'Martin Tellez Murder.'" —Anonymous 4."I wouldn't say it's a horror story, but I'm adopted, so I took the test on both 23andMe and Ancestry.com. Both tests basically confirmed what I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback